Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan D White

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Plos One|February 4, 2016
Identification of Human Islet Amyloid Polypeptide as a BACE2 SubstrateIngrid C Rulifson, Ping Cao, Li Miao, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2008
Discovery of alpha-amidosulfones as potent and selective agonists of CB2: synthesis, SAR, and pharmacokinetic propertiesIsaac E Marx, Erin F DiMauro, Alan Cheng, et al.
Medchemcomm|August 16, 2018
Development of 2-aminooxazoline 3-azaxanthene β-amyloid cleaving enzyme (BACE) inhibitors with improved selectivity against Cathepsin DJonathan D Low, Michael D Bartberger, Kui Chen, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2007
Discovery of novel 2,3-diarylfuro[2,3-b]pyridin-4-amines as potent and selective inhibitors of Lck: synthesis, SAR, and pharmacokinetic propertiesMatthew W Martin, John Newcomb, Joseph J Nunes, et al.
Neuron|January 21, 2006
Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasisHarveen Dhillon, Jeffrey M Zigman, Chianping Ye, et al.
Bioorganic & Medicinal Chemistry Letters|July 22, 2008
Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2Erin F DiMauro, John L Buchanan, Alan Cheng, et al.
The Journal of Clinical Investigation|December 3, 2005
Mice lacking ghrelin receptors resist the development of diet-induced obesityJeffrey M Zigman, Yoshihide Nakano, Roberto Coppari, et al.
Journal of Medicinal Chemistry|May 2, 2008
Discovery of aryl aminoquinazoline pyridones as potent, selective, and orally efficacious inhibitors of receptor tyrosine kinase c-KitEssa Hu, Andrew Tasker, Ryan D White, et al.
Journal of Medicinal Chemistry|November 4, 2014
Inhibitors of β-site amyloid precursor protein cleaving enzyme (BACE1): identification of (S)-7-(2-fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5'H-spiro[chromeno[2,3-b]pyridine-5,4'-oxazol]-2'-amine (AMG-8718)Thomas A Dineen, Kui Chen, Alan C Cheng, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2007
Discovery of 4-amino-5,6-biaryl-furo[2,3-d]pyrimidines as inhibitors of Lck: development of an expedient and divergent synthetic route and preliminary SARErin F DiMauro, John Newcomb, Joseph J Nunes, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Plos One|February 4, 2016
Identification of Human Islet Amyloid Polypeptide as a BACE2 SubstrateIngrid C Rulifson, Ping Cao, Li Miao, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2008
Discovery of alpha-amidosulfones as potent and selective agonists of CB2: synthesis, SAR, and pharmacokinetic propertiesIsaac E Marx, Erin F DiMauro, Alan Cheng, et al.
Medchemcomm|August 16, 2018
Development of 2-aminooxazoline 3-azaxanthene β-amyloid cleaving enzyme (BACE) inhibitors with improved selectivity against Cathepsin DJonathan D Low, Michael D Bartberger, Kui Chen, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2007
Discovery of novel 2,3-diarylfuro[2,3-b]pyridin-4-amines as potent and selective inhibitors of Lck: synthesis, SAR, and pharmacokinetic propertiesMatthew W Martin, John Newcomb, Joseph J Nunes, et al.
Neuron|January 21, 2006
Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasisHarveen Dhillon, Jeffrey M Zigman, Chianping Ye, et al.
Bioorganic & Medicinal Chemistry Letters|July 22, 2008
Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2Erin F DiMauro, John L Buchanan, Alan Cheng, et al.
The Journal of Clinical Investigation|December 3, 2005
Mice lacking ghrelin receptors resist the development of diet-induced obesityJeffrey M Zigman, Yoshihide Nakano, Roberto Coppari, et al.
Journal of Medicinal Chemistry|May 2, 2008
Discovery of aryl aminoquinazoline pyridones as potent, selective, and orally efficacious inhibitors of receptor tyrosine kinase c-KitEssa Hu, Andrew Tasker, Ryan D White, et al.
Journal of Medicinal Chemistry|November 4, 2014
Inhibitors of β-site amyloid precursor protein cleaving enzyme (BACE1): identification of (S)-7-(2-fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5'H-spiro[chromeno[2,3-b]pyridine-5,4'-oxazol]-2'-amine (AMG-8718)Thomas A Dineen, Kui Chen, Alan C Cheng, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2007
Discovery of 4-amino-5,6-biaryl-furo[2,3-d]pyrimidines as inhibitors of Lck: development of an expedient and divergent synthetic route and preliminary SARErin F DiMauro, John Newcomb, Joseph J Nunes, et al.
Pageof 3